News & Views

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix

News,

Telix is pleased to announce today that Mr. Kevin McCann AM and Dr. Mark Nelson have been appointed to the Board of Telix Pharmaceuticals Limited as Non-Executive…

Read more

Telix and Cyclotek Conclude Radiopharmaceutical Manufacturing Agreement for Australia and New Zealand

ASX, News,

Telix is pleased to announce the completion of a Master Services Agreement with Cyclotek (Aust) Pty Ltd…

Read more

Abzena and Telix Sign Licence Agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies

ASX, News,

Telix is pleased to announce a licence agreement collaboration with Abzena plc (Abzena) for its prostate-specific membrane antigen antibodies…

Read more

Telix Pharmaceuticals and Atlab Pharma Conclude Therapeutic Product Development Agreement for Prostate Cancer

ASX, News,

Telix is pleased to announce the completion of a product collaboration and purchase option agreement with Atlab Pharma SAS…

Read more

Telix Pharmaceuticals Acquires Glioblastoma Program from Therapeia

ASX, News,

Telix is pleased to announce a product development partnership with Therapeia GmbH & Co KG…

Read more

Wilex Signs Antibody License Agreement With Telix Pharmaceuticals Limited

News,

Telix is delighted to have established this licensing agreement with Wilex for an important product with the potential to significantly impact cancer…

Read more
1 … 49 50 51